Tuesday - November 25, 2025
Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release
November 24, 2025
CHICAGO, Illinois, Nov. 24 [Category: Health Care] -- The Alzheimer's Association posted the following news release:

* * *

Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release

*

Results Underscore Need for Continued Research and Diverse Treatment Pipeline

CHICAGO, Nov. 24, 2025 The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a s . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products